Valuation: Krka, d. d.

Market Cap 8.12B 9.29B 7.49B 6.89B 13.05B 894B 13.27B 89.43B 35.09B 437B 34.88B 34.11B 1,506B P/E 2026 *
19.6x
P/E 2027 * 18.6x
Enterprise Value 7.44B 8.51B 6.86B 6.31B 11.95B 819B 12.16B 81.94B 32.15B 400B 31.96B 31.26B 1,379B EV / Sales 2026 *
3.43x
EV / Sales 2027 * 3.22x
Free-Float
74.74%
Yield 2026 *
3.39%
Yield 2027 * 3.74%
1 day+1.32%
1 week+1.15%
Current month+5.79%
1 month+0.38%
3 months+8.83%
6 months+21.00%
Current year+30.54%
1 week 257
Extreme 257
268
1 month 249.5
Extreme 249.5
268
Current year 202
Extreme 202
268
1 year 174
Extreme 174
268
3 years 100
Extreme 100
268
5 years 80
Extreme 80
268
10 years 48.01
Extreme 48.01
268
Manager TitleAgeSince
Chief Executive Officer 70 2004-12-31
Director of Finance/CFO - 1996-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 59 2008-12-31
Director/Board Member 59 2004-12-31
Director/Board Member 59 2004-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.32%+1.15%+32.83%+126.50% 9.29B
-0.07%+0.59%+14.64%+80.97% 48.66B
+0.59%-0.41%+67.38%+112.51% 35.52B
-0.59%-0.82%-3.14%+38.43% 12.07B
-0.26%-0.44%+19.09%+91.34% 11.99B
-1.76%-4.19%+41.36%-6.88% 6.92B
+0.33%+0.50%+19.64%+38.14% 7B
-0.46%+0.87%+3.72%+225.58% 6.74B
+6.39%+7.36%-16.52%+20.63% 6.36B
-0.04%+4.39%+23.85%+140.87% 4.48B
Average +0.55%+1.75%+20.29%+86.81% 14.9B
Weighted average by Cap. +0.32%+1.33%+27.19%+88.38%

Financials

2026 *2027 *
Net sales 2.17B 2.48B 2B 1.84B 3.48B 238B 3.54B 23.86B 9.36B 117B 9.3B 9.1B 402B 2.3B 2.63B 2.12B 1.95B 3.69B 253B 3.76B 25.32B 9.93B 124B 9.87B 9.66B 426B
Net income 420M 480M 387M 356M 674M 46.19B 686M 4.62B 1.81B 22.57B 1.8B 1.76B 77.81B 442M 505M 408M 375M 710M 48.62B 722M 4.87B 1.91B 23.76B 1.9B 1.86B 81.91B
Net Debt -680M -778M -627M -577M -1.09B -74.84B -1.11B -7.49B -2.94B -36.58B -2.92B -2.86B -126B -708M -810M -653M -600M -1.14B -77.89B -1.16B -7.79B -3.06B -38.07B -3.04B -2.97B -131B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,204
Date Price Change Volume
26-07-12 265.00 +1.53% 7,543
26-07-15 €268.00 +1.13% 5,155
26-07-14 €265.00 0.00% 5,245
26-07-13 €265.00 +1.53% 7,543
26-07-10 €261.00 -0.76% 8,143
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
268.00EUR
Average target price
242.65EUR
Spread / Average Target
-9.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock